Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.
about
Chemophototherapy: An Emerging Treatment Option for Solid TumorsTreatment of canine hemangiopericytomas with photodynamic therapy.Photodynamic therapy with PhotoPoint photosensitiser MV6401, indium chloride methyl pyropheophorbide, achieves selective closure of rat corneal neovascularisation and rabbit choriocapillaris.In vivo fluorescence imaging of the transport of charged chlorin e6 conjugates in a rat orthotopic prostate tumour.New method for delivering a hydrophobic drug for photodynamic therapy using pure nanocrystal form of the drug.Light delivery over extended time periods enhances the effectiveness of photodynamic therapy.Photodynamic therapy of disseminated non-small cell lung carcinoma in a murine modelIL-6 potentiates tumor resistance to photodynamic therapy (PDT).Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus.Monitoring photobleaching and hemodynamic responses to HPPH-mediated photodynamic therapy of head and neck cancer: a case report.Increasing damage to tumor blood vessels during motexafin lutetium-PDT through use of low fluence rateSubstrate affinity of photosensitizers derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy.Photodynamic tumor eradication with a novel targetable photosensitizer: strong vascular effects and dependence on treatment repetition versus potentiation.Photodynamic therapy of age-related macular degeneration: History and principles.Advance in photosensitizers and light delivery for photodynamic therapyTreatment of canine oral squamous cell carcinomas with photodynamic therapy.Role of cytokines in photodynamic therapy-induced local and systemic inflammation.Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.Enzyme-activatable imaging probe reveals enhanced neutrophil elastase activity in tumors following photodynamic therapy.Efficacy of 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a in photodynamic therapy of human esophageal squamous cancer cellsPhotodynamic Therapy for Cancer and for Infections: What Is the Difference?Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles.Conjugation of 2-(1'-hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to carbohydrates changes its subcellular distribution and enhances photodynamic activity in vivoDownregulation of ICAM-1 and VCAM-1 expression in endothelial cells treated by photodynamic therapy.Structure and biodistribution relationships of photodynamic sensitizers.Novel theranostic nanoporphyrins for photodynamic diagnosis and trimodal therapy for bladder cancerNanotechnology for photodynamic therapy: a perspective from the Laboratory of Dr. Michael R. Hamblin in the Wellman Center for Photomedicine at Massachusetts General Hospital and Harvard Medical School.Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide-a methylester photosensitization.Local photodynamic therapy delays recurrence of equine periocular squamous cell carcinoma compared to cryotherapy.Distinct transduction mechanisms of cyclooxygenase 2 gene activation in tumour cells after photodynamic therapyEVALUATION OF NEW BENZOPORPHYRIN DERIVATIVES WITH ENHANCED PDT EFFICACY*
P2860
Q28468315-237E16D6-D0A1-4170-9EF4-2FE32BAE0CC6Q31001099-C7A78679-43C1-4A54-AA99-C7C782ACC0A5Q31136768-C0318181-3413-4FD5-9959-74C10F5BAA3DQ33178931-7EC5702A-01E6-4E99-8992-D32E62DF800EQ33271133-8687BFD7-0A84-4786-88F4-5328A46BBA2CQ33331297-E6808928-4BA9-4DFC-ADD6-E17E504E2D8DQ34068178-55FE0936-6C20-41C5-A1E0-9C423A103D85Q34068182-BC130999-A308-457D-8892-8FE177AAC209Q34068196-061781CD-0D9A-474B-A0BD-DC2397C2BA3CQ34240972-EEF68EAA-D51E-4B45-B695-2592CFEE4CE4Q34373293-71BF8D18-A08A-4266-8B9C-F36348D5C98FQ34472249-F45E737C-58C7-4A69-84A4-8AA139326887Q34474855-00EA3D44-918B-4A82-A7DC-48A05C192EFFQ35932469-81C7D4AC-D3FB-4AA0-85FE-2C387A72EEA7Q36609660-403959B9-E4B7-4ABC-A725-F56654141C71Q36641665-430740FF-54ED-4B5E-9BCA-CC23EF93610CQ36648974-C7F18052-3B0B-4B66-BA5B-691658819CC0Q36822754-9715D508-82D5-4770-9CFD-C51C04E21169Q37053121-CA111120-378B-4DBE-9FFC-921AC4C1E7D8Q37229356-221E727F-03E0-45E2-8B4B-794185D3EB06Q38068168-81A4E8B1-9F12-405E-9763-6048D4BB34FAQ39437627-6BD707AF-CC3B-419A-B722-E342D997496AQ39840930-DEE06CC0-2FAD-457F-9DF1-B133BB1DB534Q40507345-614A8691-362A-43DB-8CF7-13FBE34E0662Q41111962-06DA7540-0D43-4C87-8C13-195956D6177EQ41634313-DAC4AB7E-280E-44A7-8612-5F52FD0D830BQ41823406-B11CD30A-1FA0-4B7E-A5E7-523ACAB41BE9Q41919166-30E9CF8F-CAB7-41B5-8400-DB0438CC0A3AQ43668462-FDF943C7-A2C5-448F-9DD5-DDFDDF820B09Q57082905-55AE9138-8EFC-460C-BCA5-14F172F32BE7Q57972452-2DD92BB6-4183-43DF-8DE3-F39A8A0CF51A
P2860
Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Murine pharmacokinetics and an ...... -2-devinyl pyropheophorbide-a.
@ast
Murine pharmacokinetics and an ...... -2-devinyl pyropheophorbide-a.
@en
type
label
Murine pharmacokinetics and an ...... -2-devinyl pyropheophorbide-a.
@ast
Murine pharmacokinetics and an ...... -2-devinyl pyropheophorbide-a.
@en
prefLabel
Murine pharmacokinetics and an ...... -2-devinyl pyropheophorbide-a.
@ast
Murine pharmacokinetics and an ...... -2-devinyl pyropheophorbide-a.
@en
P2093
P1476
Murine pharmacokinetics and an ...... -2-devinyl pyropheophorbide-a.
@en
P2093
Bellnier DA
Dougherty TJ
Henderson BW
P356
10.1016/1011-1344(93)80131-R
P577
1993-09-01T00:00:00Z